Search Within

Marc Ladanyi

  1. "Efsevia Vakiani"
Formats
  1. Meeting Abstract (18)
  2. Journal Article (17)
Groups
  1. Department of Pathology and Laboratory Medicine (35)
  2. GSK Faculty (35)
  3. Human Oncology and Pathogenesis Program (35)
  4. Tow Center for Developmental Oncology (TCDO) (35)
  5. Department of Medicine (28)
  6. Solid Tumor Oncology Division (28)

More Groups

People
  1. Efsevia Vakiani (35)
  2. David Solit (19)
  3. Michael Berger (18)
  4. Jaclyn Hechtman (17)
  5. Jinru Shia (16)
  6. Maria Arcila (15)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (2)
  5. 2021 (1)
  6. 2020 (1)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Laboratory Investigation (5)
  3. Modern Pathology (5)
  4. Cancer Research (3)
  5. Cancer (2)
  6. Molecular Cancer Research (2)

More Publications

Publishers
  1. Nature Publishing Group (8)
  2. American Association for Cancer Research (7)
  3. American Society of Clinical Oncology (6)
  4. Nature Research (5)
  5. Wiley Blackwell (2)
  6. American Medical Association (1)

More Publishers

Results (35)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Higher proportion of frameshift mutations and tumor mutational burden in MLH1-deficient colorectal cancers with secondary alterations in MSH3 or MSH6
    Meeting Abstract

    Wang, J.; Yao, J. J.; Vakiani, E.; Weiser, M.; Stadler, Z.; Shia, J.; Ladanyi, M.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Cell free DNA (cfDNA) assessment of esophagogastric (EG) cancer using MSK-ACCESS
    Meeting Abstract

    Cytryn, S. L.; Phu, W.; Shah, R. H.; Walch, H. S.; Chatila, W. K.; Vakiani, E.; Brannon, A. R.; Ladanyi, M.; Srivastava, A.; Tang, L. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Recurrent TRAK1::RAF1 fusions in pediatric low-grade gliomas
    Journal Article

    Benhamida, J. K.; Harmsen, H. J.; Ma, D.; William, C. M.; Li, B. K.; Villafania, L.; Sukhadia, P.; Mullaney, K. A.; Dewan, M. C.; Vakiani, E.; more...
    Brain Pathology (2023)

    Fulltext@MSK | Save
  • Cell free DNA (cfDNA) assessment of esophagogastric (EG) cancer using MSK-ACCESS
    Meeting Abstract

    Cytryn, S. L.; Solit, D. B.; Walch, H. S.; Chatila, W. K.; Maron, S. B.; Vakiani, E.; Brannon, A. R.; Ladanyi, M.; Schultz, N.; Berger, M. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Molecular characterization of gallbladder cancer
    Meeting Abstract

    Giraldo, N. A.; Mohanty, A.; Vanderbilt, C.; Brannon, R.; Benayed, R.; Vakiani, E.; Abou-Alfa, G.; Harding, J.; El Dika, I.; Schultz, N.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Comprehensive molecular characterization of gallbladder carcinoma and potential targets for intervention
    Journal Article

    Giraldo, N. A.; Drill, E.; Satravada, B. A.; El Dika, I.; Brannon, A. R.; Dermawan, J.; Mohanty, A.; Ozcan, K.; Chakravarty, D.; Benayed, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS
    Journal Article

    Brannon, A. R.; Jayakumaran, G.; Diosdado, M.; Patel, J.; Razumova, A.; Hu, Y.; Meng, F.; Haque, M.; Sadowska, J.; Murphy, B. J.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Development of genome-derived tumor type prediction to inform clinical cancer care
    Journal Article

    Penson, A.; Camacho, N.; Zheng, Y.; Varghese, A. M.; Al-Ahmadie, H.; Razavi, P.; Chandarlapaty, S.; Vallejo, C. E.; Vakiani, E.; Gilewski, T.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Validation and implementation of ultra-rapid mutation and MSI assessment using the Idylla platform
    Meeting Abstract

    Nafa, K.; Momeni Boroujeni, A.; Gandia, E.; Solomon, J. P.; Vakiani, E.; Zhu, M.; Chan, R.; Elezovic, D.; Mensah, N. T.; Rijo, I.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Influence of WNT and DNA damage response pathway alterations on outcomes in patients with unresectable metastatic colorectal cancer
    Meeting Abstract

    Mondaca, S.; Walch, H. S.; Nandakumar, S.; Chatila, W. K.; Hechtman, J. F.; Cercek, A.; Diaz, L. A.; Sanchez-Vega, F.; Kemeny, N. E.; Segal, N. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save